EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue782,400560,900488,800489,331
Cost of Revenue465,100285,100233,200216,845
Gross Profit317,300275,800255,600272,486
Operating Expenses
Research Development142,800142,800142,800142,800
Selling General and Administrative181,700142,900143,100121,145
Non Recurring----
Others----
Total Operating Expenses671,800436,600383,300337,990
Operating Income or Loss110,600124,300105,500151,341
Income from Continuing Operations
Total Other Income/Expenses Net-29,100-8,240-15,986-15,625
Earnings Before Interest and Taxes110,600124,300105,500151,341
Interest Expense-9,900-6,600-7,600-6,523
Income Before Tax81,500118,60099,200135,716
Income Tax Expense18,80036,00036,70044,300
Minority Interest----
Net Income From Continuing Ops62,70082,60062,50091,416
Non-recurring Events
Discontinued Operations---10,700-28,546
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income62,70082,60051,80062,870
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares62,70082,60051,80062,870